Last reviewed · How we verify
NCT05458830
Breaking Down Barriers to a Suicide Prevention Helpline
NA trial testing Brief Barrier Reduction Intervention in Suicidal Ideation in 775 participants. Completed in 1 April 2023.
5 December 2022
Quick facts
| Lead sponsor | 113 Suicide Prevention |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 775 |
| Start date | 7 October 2022 |
| Primary completion | 5 December 2022 |
| Estimated completion | 1 April 2023 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Brief Barrier Reduction Intervention
- Plain advisory text
Conditions studied
- Suicidal Ideation — all drugs for Suicidal Ideation →
Sponsor
113 Suicide Prevention
Who can join
16 and older, any sex, with Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Every month, around four thousand people fill in the anonymous self-test for suicidal thoughts on the website of the Dutch suicide prevention helpline 113 Suicide Prevention. The self-test includes the Suicidal Ideation Attributes Scale (SIDAS) and informs people about the severity of their suicidal thoughts. The vast majority (70%) of people who complete the test score higher than the cut-off point (≥ 21) for severe suicidal thoughts. Despite this, only around 10% of test-takers navigate to the webpage about contacting the helpline. In this study the investigators test an intervention that aims to reduce barriers to contacting the helpline via chat or phone. People with severe suicidal thoughts and little motivation to contact the helpline will be randomly allocated either to a brief Barrier Reduction Intervention (BRI) or care as usual, a plain advisory text. The aim of our study is two-fold: (i) to measure the effectiveness of a brief barrier reduction intervention (BRI) in the self-test motivating people with severe suicidal thoughts to contact the helpline, and (ii) to specifically evaluate the effectiveness of the intervention in increasing service utilisation by high-risk groups for suicide such as men and people of middle age.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Breaking Down Barriers to a Suicide Prevention Helpline: Protocol for a Web-Based Randomized Controlled Trial.
van der Burgt MCA, Mérelle S, Brinkman WP, Beekman ATF, et al · · 2023 · cited 2× · PMID 37093641 · DOI 10.2196/41078 -
Breaking Down Barriers to a Suicide Prevention Helpline: Web-Based Randomized Controlled Trial.
Van der Burgt MCA, Mérelle S, Brinkman WP, Beekman ATF, et al · · 2024 · cited 1× · PMID 39235321 · DOI 10.2196/56396
Verify or expand the search:
- PubMed search for NCT05458830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicidal Ideation
Currently open trials in the same condition.
- NCT07438912 — Mind After Midnight · NA · recruiting
- NCT07238192 — Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD · NA · recruiting
- NCT07217444 — Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation · NA · recruiting
- NCT07259408 — Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior · recruiting
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
Other 113 Suicide Prevention trials
Trials by the same sponsor.
- NCT06370104 — Treating Suicidality Remotely · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05458830 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by 113 Suicide Prevention
- Last refreshed: 13 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05458830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing